Delivery Order SPE2DB20D3505-SPE2DB24FT5G7
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NovologĀ® 100 unit/mL FlexPen 3mL. The $2,445.30 firm-fixed-price contract has a completion date of December 6, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL, a medical product used for diabetes management. The contract has a ceiling value of $1,548.00 and runs through November 30, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of NovologT 100 Unit/mL Flexpen 3mL, a pharmaceutical product. The award has a ceiling value of $1,656.72 and an ultimate completion date of September 23, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NovoLog 100 unit/mL Flexpen, a prescription insulin product, at a ceiling value of $1,535.40. The contract has a period of performance through May 15, 2024 and is a firm fixed price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The delivery order has a ceiling value of $2,408.19 and a completion date of May 30, 2025. The contract is a firm fixed price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a ceiling value of $6,798.66 and a period of performance through May 23, 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NovologTM 100 unit/mL FlexPen 3mL, a diabetes medication. The contract is a firm-fixed-price delivery order with a ceiling value of $2,811.60 and a period of performance through April 30, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,790.81 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564589907 NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a period of performance through May 14, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of NovologTM 100 unit/mL FlexPenTM 3mL, a pharmaceutical product. The contract has a ceiling value of $4,084.80 and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovologTM 100 unit/mL Flexpen 3 mL. The contract has a ceiling value of $1,433.68 and a completion date of July 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT5G7Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovologR 100 Unit/mL FlexPen 3mL. The contract has a ceiling value of $1,320.85 and runs through December 29, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is likely one of many under that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/28/23 |